行情

BIO

BIO

Bio Rad实验室
NYSE

实时行情|Nasdaq Last Sale

364.12
+5.84
+1.63%
已收盘, 16:00 11/19 EST
开盘
359.59
昨收
358.28
最高
365.79
最低
358.64
成交量
12.23万
成交额
--
52周最高
365.79
52周最低
220.05
市值
109.00亿
市盈率(TTM)
34.51
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

BIO 新闻

  • The Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy Readout
  • Benzinga.21小时前
  • 金斯瑞生物与韩国著名药企达成重大开发合作
  • 中国网财经.2天前
  • Edited Transcript of BIO earnings conference call or presentation 31-Oct-19 9:00pm GMT
  • Thomson Reuters StreetEvents.2天前
  • The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval
  • Benzinga.4天前

更多

所属板块

医疗设备、用品及经销
+0.71%
医疗设备和用品
+1.01%

热门股票

名称
价格
涨跌幅

BIO 简况

Bio-Rad Laboratories, Inc. (Bio-Rad) is a manufacturer and distributor of its life science research and clinical diagnostics products. The Company operates through two segments: Life Science and Clinical Diagnostics. It manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Life Science segment develops, manufactures, sells and services reagents, apparatus and instruments used for biological research. The Clinical Diagnostics segment develops, manufactures, sells and services automated test systems, informatics systems, test kits and specialized quality controls for the healthcare market. As of December 31, 2016, Bio-Rad sold more than 8,000 products and services to a client base, including scientific research, healthcare, education and government customers around the world.
展开

Webull提供Bio-Rad Laboratories, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。